CMP
Director Trades
| Date | Director | Value |
|---|---|---|
| 18/11/24 | D. Burton | $50,000 |
Company News
Compumedics Looks to Turn the Corner after Record Sales And Growth in FY25
Compumedics (ASX: CMP) has marked a strategic turning point in its development after posting record sales and profitable growth for the 2025 financial year. The company racked up $63.4 million in sales for the period, representing a growth of 22% on the previous year. Its EBITDA increased to approximately $3m, returning Compumedics to profitability and […]
Compumedics reaches $20m in Chinese MEG sales with latest university contract
Brain research technologies specialist Compumedics (ASX: CMP) has reached $20 million in sales for its magnetoencephalography (MEG) system in China. The latest $5.7m contract from Hangzhou Normal University follows the successful installation of a MEG system at Tianjin Normal University and further orders from Tsinghua and Tianjin universities. MEG is a neuroimaging technique for mapping […]
Compumedics eyes US market with Somfit sleep diagnostic device
Brain research technology specialist Compumedics (ASX: CMP) has achieved a major breakthrough with the planned distribution of its Somfit sleep assist system, with the Food & Drug Administration (FDA) clearing the device to be marketed in the United States. Compumedics is targeting the multi-million dollar sleep market in the US with the Somfit technology, which […]
US FDA approves Compumedics’ MEG neuroimaging technology enabling insurers to be billed
Compumedics (ASX: CMP) has collared US Food and Drug Administration approval for its neuroimaging technology, enabling insurers to be billed for the scan. On Friday, the FDA officially granted 510(K) clearance to Compumedics for its Orion LifeSpan Magnetoencephalography (MEG) single Dewar system. Compumedics’ MEG is a neuroimaging technique that maps brain activity by recording magnetic […]
Compumedics boosts after tax profit by 133%
Compumedics (ASX: CMP) has delivered a net after tax profit of $2.8 million for the full year ending June 2018 – an increase of 133% on the previous year’s $1.3 million. Meanwhile, earnings before interest tax depreciation and amortisation grew 55% during 2018 to $4.2 million, compared to $2.7 million in 2017. This 55% improvement […]
Compumedics’ new distribution agreement strengthens ongoing growth in Asia’s neuro-diagnostic and monitoring market
Australia-based medical device company Compumedics (ASX: CMP) has continued its ongoing development and focus in Asia with a new three-year distribution agreement with one of Japan’s leading medical device companies, Fukuda Denshi Co Ltd. The A$3.6 million agreement is part of the company’s growing trend in sales for its neuro-diagnostic and monitoring products in the Asian […]
Compumedics plans to ‘make history’ with Somfit health joint venture in China
Compumedics (ASX: CMP) has entered into an agreement with leading China-based health-check organisation Meinian Onehealth Healthcare Holdings (Health 100) to work together over the next 90 days to finalise a formal joint venture that enables the companies to commercialise Compumedics’ Somfit technology in China. The Somfit platform is a mobile wearable system that monitors sleep […]
Compumedics signs major distribution agreements in China worth at least A$15m
Compumedics (ASX: CMP) has negotiated a new distribution agreements with three of the company’s long-standing distributors in China, for its sleep, neuro-diagnostic and monitoring systems. The agreements are worth approximately A$15 million (US$11.3m) in minimum sales commitments over the next three years to the company. In addition, a new A$1.5 million (US$1.1m) order has been […]
Compumedics confirms sustainable profitability with contract win and continued eHealth growth forecast
One of Australia’s leading medical device companies, Compumedics (ASX: CMP), announced this week, record sales orders of A$18.5 million for first half year having secured its largest system contract in the company’s history worth A$4.93 million. The contract, which will see Compumedics’ supplying its magnetoencephalography (MEG) imaging system to the world-renowned Barrow Neurological Institute (BNI) […]